Arrowhead Pharmaceuticals
ARWR
#2218
Rank
C$12.34 B
Marketcap
C$87.66
Share price
-0.10%
Change (1 day)
67.53%
Change (1 year)

P/S ratio for Arrowhead Pharmaceuticals (ARWR)

P/S ratio as of October 2026 (TTM): 12.9

According to Arrowhead Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 18.5. At the end of 2026 the company had a P/S ratio of 16.6.

P/S ratio history for Arrowhead Pharmaceuticals from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202616.693.2%
20258.59-99.09%
20249445117.14%
202318.19.07%
202216.6-65.44%
202148.0-51.41%
202098.8151.89%
201939.261.22%
201824.3169.8%
20179.01-64.88%
201625.7-98.22%
2015> 10007.55%
2014> 1000-44.71%
2013> 10001936.39%
2012119-93.55%
2011> 100012700.49%
201014.439.13%
200910.3-57.95%
200824.6-72.88%
200790.6-78.6%
2006424111.8%
20052006.9%
2004187547.7%
200328.9126.56%
200212.7-11.98%
200114.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.40-50.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
34.7 169.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
20.4 58.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
6.28-51.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA